Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Inflammatory Breast Neoplasms × Docetaxel × 1 year × Clear all

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 69 Breast Neoplasms 47 Prostatic Neoplasms 41 Squamous Cell Carcinoma of Head and Neck 33 Lung Neoplasms 23 Neoplasms 20 Neoplasm Metastasis 16 Stomach Neoplasms 15 Head and Neck Neoplasms 14 Urinary Bladder Neoplasms 12 Triple Negative Breast Neoplasms 12 Carcinoma, Transitional Cell 10 Parkinson Disease 4, Autosomal Dominant Lewy Body 9 Ovarian Neoplasms 8 Endometrial Neoplasms 8 Adenocarcinoma 8 Melanoma 7 Carcinoma, Squamous Cell 7 Small Cell Lung Carcinoma 6 Prostatic Neoplasms, Castration-Resistant 6 Non-Muscle Invasive Bladder Neoplasms 6 HER2-positive Breast Cancer 6 Esophageal Neoplasms 6 Carcinoma 6 Esophageal Squamous Cell Carcinoma 5 Colorectal Neoplasms 5 Advanced Solid Tumors 5 Uterine Cervical Neoplasms 4 Sarcoma 4 Salivary Gland Neoplasms 4

Interventions

Paclitaxel 6 Cyclophosphamide 5 Doxorubicin 4 pembrolizumab 3 eribulin 3 Taxes 3 pertuzumab 2 Trastuzumab 2 Specimen Handling 2 Radiotherapy 2 trastuzumab biosimilar HLX02 1 ruxolitinib 1 romidepsin 1 onvansertib 1 olaparib 1 neratinib 1 grapiprant 1 cobimetinib 1 caficrestat 1 atezolizumab 1 X-Rays 1 Therapeutics 1 Tamoxifen 1 Surgical Procedures, Operative 1 Radiation 1 Peripheral Blood Stem Cell Transplantation 1 Panitumumab 1 Palliative Care 1 PF-05280014 1 Ontruzant 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡